About

Carolina Dantas (MD) brings her expertise as a pulmonologist to Pulmotree, providing the valuable insight of both physicians and patients. Specialising in respiratory infectious diseases and lung-related indications, such as cystic fibrosis and bronchiectasis, she has vast hands-on clinical experience with inhaled drug therapies.

As Manager of Medical and Scientific Affairs, her search for innovation in healthcare matches Pulmotree’s forward-thinking approach to the evolution of respiratory therapies. Besides her knowledge in clinical research, Dr Dantas is an accomplished communicator in science, with several published scientific papers, a book chapter and several original presentations at international conferences.

Dr Dantas holds a master’s degree in Medicine, and is a member of the Sociedade Portuguesa de Pneumologia, the European Respiratory Society (ERS) and the International Society for Aerosols in Medicine.

Contributions

EXPERT VIEW

EXPLORING THE POTENTIAL OF NEBULISED BIOLOGICS

Carolina Dantas and Ulf Krueger consider the challenges when it comes to the successful delivery of inhaled biological drugs.

More contributions

EXPERT VIEW

THE IMPORTANCE OF THE BREATHING MANOEUVRE IN NEBULISED THERAPIES

Carolina Dantas and Ulf Krueger highlight the importance of the breathing manoeuvre in nebulised therapies – and describe a small study designed to test the effectiveness of patient feedback technology when it comes to guiding the inhalation manoeuvre.

EXPERT VIEW

THE POTENTIAL OF CONNECTIVITY AND MONITORING IN MESH NEBULISERS

Carolina Dantas and Ulf Krueger review the current connectivity and remote monitoring capabilities in mesh nebulisers – and their potential to impact patients’ healthcare journeys and the clinical development of inhaled therapies.